Company intelligence / Profile preview

Icon Genetics

Halle/Saale, Saxony-Anhalt, Germanyicongenetics.com ↗

Ownership: Private
Employees: ~12
Development stage: Other

Overview

Icon Genetics has developed the magnICON® platform for efficient transient expression of recombinant proteins in green plants. This technology addresses speed, yield, precision, flexibility, and regulatory requirements for biopharmaceuticals and diagnostics. The company has a strong patent portfolio (>400 patents) and experience running FDA-approved clinical trials. It operates a GMP-certified R&D facility with EU GMP-compliant quality management systems. Its pipeline includes preventive/therapeutic vaccines and diagnostic proteins but specific clinical results are not publicly detailed.

Therapeutic areas: OtherInfectious Diseases
Modalities: Recombinant proteinVaccine (plant-based)BiologicProteinDiagnostic protein (recombinant)Vaccine (preventive and therapeutic)
Industry: Biotech

Drug pipeline

2 assets

rNV-2v

1 more asset in the full pipeline.

Partnerships

Previously partnered/acquired by Bayer Innovation GmbH/Bayer AG; current partnerships not specified.

Beyond the preview

Go deeper on Icon Genetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Icon Genetics.